Switching Patients With Congenital Adrenal Hyperplasia to Modified-Release Hydrocortisone Capsules: Relative Bioavailability and Disease Control. - Ross RJM; Arlt W; de la Perriere AB; Hirschberg AL; Juul A; Merke DP; Newell-Price JDC; Prete A; Rees DA; Reisch N; Stikkelbroeck M; Touraine PA; et al. (Clinical endocrinology, 2025)